×

Disclaimer

Crosslink Capital, Inc. (“Crosslink”) was recently informed that someone or an organization has been impersonating it and one or more of its employees on the mobile application WhatsApp.

Crosslink does not market its services and Crosslink and its employees do not provide investment advice through WhatsApp or any similar social media messaging application, and anyone who does so purporting to act in Crosslink’s name or the name of any of its employees is not in any way connected to Crosslink or Crosslink Capital Management, LLC. Crosslink employees provide investment advice only through Crosslink. Crosslink provides investment advice only to investment funds or clients, in each case, with whom it has entered into a written contract. Crosslink does not provide investment or other advice to non-clients.

You can look up investment advisers and their registered persons at: https://adviserinfo.sec.gov/

For more information investing generally, please see: https://www.investor.gov/

February 22, 2022

Overjet Secures U.S. Patent for its Revolutionary AI Technology Enabling Accurate Measurements on Dental X-rays

BOSTONFeb. 22, 2022 /PRNewswire/ — Overjet, a leader in dental artificial intelligence solutions for DSOs and insurance companies, announced today that it has secured a United States Patent (U.S. Patent No. 11158046B2) for its invention of breakthrough AI technology to accurately measure anatomical structures and quantify disease on dental X-rays.

Before Overjet’s invention, it was impossible for any software to accurately measure distances in dental X-rays without using calibration objects during the image capture. Overjet’s new AI technology eliminates the need for foreign calibration objects. Using deep learning, Overjet’s software can identify anatomical features — individual teeth, restorations, implants, CEJ, bone levels and other physical attributes — to equip dental professionals to make accurate calibrated measurements and to determine pixel-to-millimeter ratio of an image.

“Enhancing clinical decision-making to improve oral health is cornerstone to everything we do at Overjet,” said Dr. Wardah Inam, PhD, CEO and Co-founder of Overjet. “We strive to deliver the best possible results for providers, payors, and patients through continued innovations in dental AI. We are incredibly proud of the U.S. Patent Office’s recognition of Overjet’s leadership in pioneering transformational dental technologies that advance patient care.” Read rest here